Back To Policy Hub

Comment Letters

July 2026

2026.07.13 TAHP UMCM Quality Comments

2026.07.13 TAHP Comments to HHSC on UMCM 3.36

June 2026

2026.06.09 OIG RAC Proposal Comments

2026.05.28 TDI Medigap Proposal Comments

2026.06.08 TAHP Physician Ranking Comments

2026.06.09 TAHP RAC Proposal Comments to OIG

May 2026

2026.05.14 TAHP Responses to TPI Round 1 Stakeholder Questions

January 2026

2026.01.19 TAHP Comments to State Board of Pharmacy in Support of Electronic Transmission Patient Counseling Information

December 2025

2025.12.08 TAHP Letter to TDI on Physician Ranking (SB 926)

August 2025

2025.08.20 Letter to TDI on Uniform Coordination of Benefits Questionnaire Rule (HB 388)

October 2024

TAHP Comments on HB 3286 Temporary Non-Preferred Revised Draft Policy

2024.10.08 Comments on PDL Exceptions Rules as Implemented by HB 3286

November 2023

TAHP Recommends HHSC Request Funding for Mental Health in 2026-27 LAR

TAHP Recommends Medicaid Cost Containment Initiatives to HHSC

October 2023

TAHP Comments on Incomplete Prior Authorization Rules

TAHP Comments on Ambulance and ERISA Opt in Surprise Billing Rules (HB 1592 & SB 2476)

August 2023

TAHP Comments on Proposed Rule Amendments Concerning the eHAC Extension

TAHP Comments on Proposed Chemical Dependency Rule

July 2023

TAHP’s Comments to HHSC on Outpatient Hospital Reimbursement Methodology

March 2023

TAHP Comments to TDI on Proposed Changes to 28 TAC

February 2023

TAHP Comment to TDI on Extraterritoriality

January 2023

2023.01.26 TAHP Comments to Proposed HB 4 Rules

2023.01.10 AG Opinion on SB 1207